Novartis gains full FDA nod for Fabhalta in kidney disorder IgAN
With two approved medicines to treat primary immunoglobulin A nephropathy (IgAN) and a third therapy in phase 3…
Novartis’ Pluvicto unlocks substantial new patient pool
Novartis’ blockbuster radioligand therapy Pluvicto has cleared a key milestone on its quest to hit $5 billion in…
Novartis (SWX:NOVN) Wins Full FDA Nod For Fabhalta And Wider EU Itvisma Use
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Novartis…
Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
F. Hoffmann-La Roche Ltd The new VENTANA PTEN (SP218) RxDx Assay fulfils an unmet medical need by helping…
Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
F. Hoffmann-La Roche Ltd The new VENTANA PTEN (SP218) RxDx Assay fulfils an unmet medical need by helping…
Jazz, Roche’s small cell lung cancer combo snags FDA approval
An FDA approval is setting a new benchmark for future treatment for first-line small cell lung cancer. The…
FDA Approves First Generic Version of Roche’s Flu Drug
The U.S. Food and Drug Administration has approved the first generic version of Roche’s flu treatment Tamiflu, marking…
FDA Approves Roche PTEN Assay for Prostate Cancer Protein Deficiency
Roche announced that the Food and Drug Administration (FDA) approved the Ventana PTEN (SP218) RxDx Assay, an immunohistochemistry…
Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
F. Hoffmann-La Roche Ltd The new VENTANA PTEN (SP218) RxDx Assay fulfils an unmet medical need by helping…
Roche wins FDA nod for PTEN-loss prostate test
Roche (OTCQX:RHHBY) received FDA approval for the VENTANA PTEN (SP218) RxDx Assay, the…
Roche, Lilly’s blood test for Alzheimer’s diagnosis gets US approval
Roche, Lilly’s blood test for Alzheimer’s diagnosis gets US approval –…
How Investors Are Reacting To Roche Holding (SWX:ROG) FDA Approval and Breakthrough Clinical Trial Results
Roche announced a series of major product milestones, including FDA approval for Gazyva in lupus nephritis and positive…